This is a London news story, published by Guardian, that relates primarily to Janusz Racz news.
For more London news, you can click here:
more London newsFor more Janusz Racz news, you can click here:
more Janusz Racz newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from Guardian, you can click here:
more news from GuardianOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
first mRNA lung cancer vaccine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest cancer vaccines news, lung cancer research news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
lung cancer vaccine trialGuardian
•
62% Informative
New jab instructs the body to hunt down and kill cancer cells then prevents them ever coming back.
Known as BNT116 and made by BioNTech, the vaccine is designed to treat non-small cell lung cancer ( NSCLC ), the most common form of the disease.
Janusz Racz , 67 , from London , was the first person to have the vaccine in the UK .
He received six consecutive injections five minutes apart over 30 minutes on Tuesday .
VR Score
61
Informative language
60
Neutral language
14
Article tone
informal
Language
English
Language complexity
46
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links